Literature DB >> 23461061

C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway.

Gang Han1, Yan Wang, Wenzhi Bi.   

Abstract

Osteosarcoma is a highly metastatic malignancy often with poor prognosis. c-Myc amplification is implicated in osteosarcoma pathogenesis. However, the role of c-myc overexpression in osteosarcoma cell invasion remains unexplored. This study showed that c-myc overexpression enhanced MG-63 and SAOS-2 osteosarcoma cell invasion. Treatment of MEK inhibitor PD98059 or PI3K inhibitor LY294002 decreased cell invasion along with downregulation of MMP-2 and MMP-9 expression. c-Myc overexpression stimulated MEK-ERK pathway whereas inhibited the activity of PI3K-AKT pathway. Specifically, inhibition of MEK-ERK pathway by PD98509 blocked the enhancement effect on cell invasion as well as MMP-2 and MMP-9 expression. The present study demonstrates that c-myc overexpression promotes osteosarcoma cell invasion, probably via activation of MEK-ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23461061     DOI: 10.3727/096504012x13522227232237

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  30 in total

1.  MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.

Authors:  Xinzhen Guo; Jie Zhang; Jianfeng Pang; Sheng He; Guojun Li; Yang Chong; Chao Li; Zhijian Jiao; Shiqian Zhang; Ming Shao
Journal:  Tumour Biol       Date:  2016-01-14

2.  Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.

Authors:  Justin M Balko; Jennifer M Giltnane; Kai Wang; Luis J Schwarz; Christian D Young; Rebecca S Cook; Phillip Owens; Melinda E Sanders; Maria G Kuba; Violeta Sánchez; Richard Kurupi; Preston D Moore; Joseph A Pinto; Franco D Doimi; Henry Gómez; Dai Horiuchi; Andrei Goga; Brian D Lehmann; Joshua A Bauer; Jennifer A Pietenpol; Jeffrey S Ross; Gary A Palmer; Roman Yelensky; Maureen Cronin; Vincent A Miller; Phillip J Stephens; Carlos L Arteaga
Journal:  Cancer Discov       Date:  2013-12-19       Impact factor: 39.397

Review 3.  Biomarkers of residual disease after neoadjuvant therapy for breast cancer.

Authors:  Frederique Penault-Llorca; Nina Radosevic-Robin
Journal:  Nat Rev Clin Oncol       Date:  2016-02-09       Impact factor: 66.675

4.  miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met.

Authors:  Guangfeng Niu; Bin Li; Jianmin Sun; Li Sun
Journal:  Cell Prolif       Date:  2015-04-16       Impact factor: 6.831

5.  Bafetinib Suppresses the Transcription of PD-L1 Through c-Myc in Lung Cancer.

Authors:  Xi Chen; Qianqian Du; Hongjie Guo; Qiaojun He; Bo Yang; Ling Ding
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

6.  MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN.

Authors:  Yao-Qi Yang; Jin Qi; Jian-Qiang Xu; Ping Hao
Journal:  Tumour Biol       Date:  2014-07-18

7.  Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.

Authors:  Jessica M Foley; Donald J Scholten; Noel R Monks; David Cherba; David J Monsma; Paula Davidson; Dawna Dylewski; Karl Dykema; Mary E Winn; Matthew R Steensma
Journal:  J Transl Med       Date:  2015-04-02       Impact factor: 5.531

8.  Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.

Authors:  Cecilia Gola; Diana Giannuzzi; Andrea Rinaldi; Selina Iussich; Paola Modesto; Emanuela Morello; Paolo Buracco; Luca Aresu; Raffaella De Maria
Journal:  Front Vet Sci       Date:  2021-05-17

9.  miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A.

Authors:  Dawei Yang; Guangpeng Liu; Kunzheng Wang
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

10.  Genomic Analysis Revealed Mutational Traits Associated with Clinical Outcomes in Osteosarcoma.

Authors:  Xiying Chi; Tao Ji; Junying Li; Jie Xu; Xiaodong Tang; Lu Xie; Fanfei Meng; Wei Guo
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.